CORTI, FRANCESCA

CORTI, FRANCESCA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 13 di 13 (tempo di esecuzione: 0.003 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter? 2022 Pietrantonio, FilippoSartore-Bianchi, AndreaCorti, FrancescaMauri, Gianluca + Article (author) -
Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis 2019 Galli GCavalieri SNichetti FCorti Fde Braud FPlatania MDel Vecchio M + Article (author) -
Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis 2019 Pusceddu, SaraGhidini, MicheleCorti, FrancescaNiger, MonicaNichetti, FedericoCabiddu, Maryde Braud, FilippoPetrelli, Fausto + Article (author) -
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden 2020 Pietrantonio FRandon GRaimondi APagani FPrisciandaro MCorti FMarra ACurigliano Gde Braud F. + Article (author) -
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers 2022 Niger, MonicaNichetti, FedericoPircher, ChiaraVingiani, AndreaAgnelli, LucaPusceddu, SaraCorti, FrancescaPrisciandaro, MicheleBini, MartaPruneri, GiancarloMazzaferro, VincenzoPietrantonio, Filippode Braud, Filippo + Article (author) -
Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors 2021 Pietrantonio, FilippoCorti, FrancescaInfante, GabrieleCurigliano, GiuseppeAmbrosini, MargheritaDamian, Silvia + Article (author) -
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors 2021 Corti, FrancescaAmbrosini, MargheritaManca, PaoloRaimondi, AlessandraPrisciandaro, MicheleCurigliano, GiuseppeDe Braud, FilippoDi Bartolomeo, MariaPietrantonio, Filippo + Article (author) -
Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors 2017 Pusceddu, SaraVernieri, ClaudioCORTI, FRANCESCADe Braud, Filippo + Article (author) -
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak : COVID-19-adapted Recommendations of the National Cancer Institute of Milan 2020 Pietrantonio, FilippoPrisciandaro, MicheleRandon, GiovanniCorti, FrancescaAmbrosini, MargheritaSposito, CarloMazzaferro, Vincenzode Braud, Filippo + Article (author) -
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives 2019 Corti, FrancescaNichetti, FedericoRaimondi, AlessandraNiger, MonicaPruneri, Giancarlode Braud, FilippoPusceddu, Sara + Article (author) -
The Pan-Immune-Inflammation Value in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitors 2021 Corti, FrancescaAmbrosini, MargheritaCurigliano, Giuseppede Braud, FilippoPietrantonio, Filippo + Article (author) -
Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trial 2020 Pietrantonio FManca PPagani FRaimondi APrisciandaro MRandon GCorti Fde Braud F + Article (author) -
“Systemic strategy at the patient’s service”: A congress report on supportive care in oncology 2017 NichettiFederico; LobefaroRiccardo; PaganiFilippo; RandonGiovanni; CortiFrancesca; De Braud + Article (author) -